中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
9期
1477-1477,1479
,共2页
银杏达莫%奥扎格雷注射液%脑梗塞
銀杏達莫%奧扎格雷註射液%腦梗塞
은행체막%오찰격뢰주사액%뇌경새
Gingko dipyridamole%Ozagrel injection%Cerebral infarction
目的：观察脑梗塞患者应用银杏达莫联合奥扎格雷注射液治疗的临床疗效。方法：我科收治的脑梗塞患者共70例,随机分为银杏达莫联合奥扎格雷注射液治疗组(观察组)和单用奥扎格雷注射液治疗组(对照组)各35例,观察两组的治疗效果及不良反应发生率。结果：观察组中总有效率为97.13%,明显高于对照组的总有效率85.72%。两组对比,P<0.05,有统计学意义；不良反应发生率两组未见明显异常。结论：银杏达莫联合奥扎格雷注射液治疗临床效果显著且安全,临床可应用。
目的：觀察腦梗塞患者應用銀杏達莫聯閤奧扎格雷註射液治療的臨床療效。方法：我科收治的腦梗塞患者共70例,隨機分為銀杏達莫聯閤奧扎格雷註射液治療組(觀察組)和單用奧扎格雷註射液治療組(對照組)各35例,觀察兩組的治療效果及不良反應髮生率。結果：觀察組中總有效率為97.13%,明顯高于對照組的總有效率85.72%。兩組對比,P<0.05,有統計學意義；不良反應髮生率兩組未見明顯異常。結論：銀杏達莫聯閤奧扎格雷註射液治療臨床效果顯著且安全,臨床可應用。
목적：관찰뇌경새환자응용은행체막연합오찰격뢰주사액치료적림상료효。방법：아과수치적뇌경새환자공70례,수궤분위은행체막연합오찰격뢰주사액치료조(관찰조)화단용오찰격뢰주사액치료조(대조조)각35례,관찰량조적치료효과급불량반응발생솔。결과：관찰조중총유효솔위97.13%,명현고우대조조적총유효솔85.72%。량조대비,P<0.05,유통계학의의；불량반응발생솔량조미견명현이상。결론：은행체막연합오찰격뢰주사액치료림상효과현저차안전,림상가응용。
Objective:To observe the clinical effectiveness of gingko dipyridamole combined with ozagrel injection in the treatment of patients with cerebral infarction.Methods:70 patients with cerebral infarction in our department were randomly divided into gingko dipyridamole combined with ozagrel injection treatment group,ozagrel (observation group) and single-injection treatment group.Ozagrel (control group),observed the therapeutic effect of the two groups and the incidence of adverse reactions.Results:Patients in observation group, the total effective rate was 97.13%, significantly higher than the total efficiency of 85.72%.Between two groups,P<0.05,significant;i ncidence of adverse reactions between the two groups showed no abnormalities.Conclusion:Clinical effectiveness of gingko dipyridamole combined with ozagrel Injection in treatment of patients with cerebral infarction was remarkable and safe,clinical application.
